# Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy

> **NCT02570412** · — · NO_LONGER_AVAILABLE · sponsor: **CytRx**

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** aldoxorubicin

## Key facts

- **NCT ID:** NCT02570412
- **Lead sponsor:** CytRx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02570412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02570412, "Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02570412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*